Article
NMR Analyses of the Activation of the Arp2/3 Complex by Neuronal Wiskott−Aldrich Syndrome Protein†
Supported by grants from the NIH (P01GM066311 to M.K.R. and R.L. and GM59609 to M.D.W.) and the Welch Foundation (I1544 to M. K. R.). E.D.G. is supported by an NSF graduate research fellowship.
Department of Biochemistry, University of Texas Southwestern Medical Center.
Current address: Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Ave., Silver Spring, MD 20910.
University of California, Berkeley.
Center for Biomedical Inventions, University of Texas Southwestern Medical Center.
Stowers Institute for Medical Research.
Varian Instruments.
To whom correspondence should be addressed. E-mail: mrosen@biochem.swmed.edu. Phone: 214-645-6361. Fax: 214-645-6353.
Abstract

The VCA domain of the neuronal Wiskott−Aldrich syndrome protein (N-WASP) is a potent activator of the Arp2/3 complex, a 240 kDa heteroheptameric actin-nucleating assembly. We used site-directed spin labeling of N-WASP peptides in conjunction with methyl-TROSY spectra of the intact, selectively labeled Arp2/3 complex to identify regions of the VCA that are proximal to the ARPC3 subunit of the assembly. We also cross-linked CA peptides to the Arp3, Arp2, ARPC1, and ARPC3 subunits. The combined data suggest that the extreme C-terminus of the A region and the C-terminus of the C region of N-WASP are proximal to ARPC3. These results have implications for the mechanism of Arp2/3 complex activation by VCA peptides. This study also demonstrates the utility of NMR spectroscopy for studying ligand binding events in large, asymmetric, macromolecular assemblies.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue November 22, 2005
- Received June 4, 2005
Revised Manuscript Received September 28, 2005
Cart





